First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
To our knowledge, the first results from NURE-Combo trial suggest that this combination could expand the therapeutic opportunities of immune-chemotherapy in patients with MIBC.
Authors
- Giuseppe Basile (ORCID: https://orcid.org/0000-0002-7227-7821)
- D. Patanè
- Matteo Bellone (ORCID: https://orcid.org/0000-0002-2586-2569)
- Francesco De Cobelli (ORCID: https://orcid.org/0000-0003-4014-3711)
- Valentina Tateo (ORCID: https://orcid.org/0000-0002-1199-2338)
- Benedetta Mattorre
- Alberto Briganti (ORCID: https://orcid.org/0000-0002-2178-0494)
- Dean C. Pavlick (ORCID: https://orcid.org/0000-0001-6075-6246)
- Renzo Colombo (ORCID: https://orcid.org/0000-0002-5627-6052)
- Roberta Lucianò (ORCID: https://orcid.org/0000-0003-0344-614X)
- Giorgio Brembilla (ORCID: https://orcid.org/0000-0002-9690-8624)
- Chiara Re (ORCID: https://orcid.org/0000-0001-8908-0817)
- Antonio Cigliola (ORCID: https://orcid.org/0009-0005-7109-2429)
- Daniele Raggi (ORCID: https://orcid.org/0000-0002-4185-2475)
- Brigida Anna Maiorano (ORCID: https://orcid.org/0000-0001-5423-3158)
- Andrea Necchi (ORCID: https://orcid.org/0000-0002-3007-2756)
- Marco Moschini (ORCID: https://orcid.org/0000-0002-3084-2458)
- Chiara Mercinelli (ORCID: https://orcid.org/0000-0003-1165-1776)
- Laura Lucia Cogrossi (ORCID: https://orcid.org/0000-0002-7479-4320)
- Maurizio Colecchia (ORCID: https://orcid.org/0000-0003-1914-0743)
- Jeffrey S. Ross (ORCID: https://orcid.org/0000-0001-8494-2596)
- Francesco Montorsi
- Giovanni Luigi Pastorino
Institutions
- Vita-Salute San Raffaele University (IT)
- SUNY Upstate Medical University (US)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Azienda Ospedaliera Universitaria Pisana (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- Foundation Medicine (United States)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1200/jco.24.00576
- Citations
- 15
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.59